Protalix BiotherapeuticsPLX

13F holders, Q3 2024 (September 30)
45holders −21
6new positions
27sold out
3famous investors
$1.03avg. 13F price*

At the end of Q3 2024, 45 institutions reported holding Protalix Biotherapeutics Inc. (PLX) in their 13F filings, down 21 from Q2 2024. 6 opened new positions and 27 sold out. The largest holders were Renaissance Technologies ($975K), Gsa Capital Partners LLP ($444K) and Millennium Management ($381K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Protalix Biotherapeutics Inc.
CUSIP
74365A309
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 63Q1 2024Q2 2024: 66Q2 2024Q3 2024: 45Q3 2024Q4 2024: 45Q4 2024Q1 2025: 63Q1 2025Q2 2025: 63Q2 2025Q3 2025: 77Q3 2025Q4 2025: 83Q4 2025Q1 2026: 100Q1 2026Q2 2026: 101Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions6$432K
Exits27$971K

All 13F filers, Q2 2024 → Q3 2024: 662,822 shares bought and 2,713,694 shares sold, net −2,050,872 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 45 holders

Renaissance Technologies 0.00% Add +18.8% 955,900 $975K
Gsa Capital Partners LLP 0.03% Add +8.5% 435,213 $444K
Millennium Management 0.00% Reduce -53.9% 373,757 $381K
Stratos Wealth Partners, LTD. 0.00% New 270,000 $275K
Bridgeway Capital Management, LLC 0.00% No change 183,790 $187K
BlackRock, Inc. 0.00% — 178,784 $182K
Citadel Advisors 0.00% Add +396.3% 91,658 $93K
Orin Green Financial, LLC 0.03% No change 72,000 $73K
Susquehanna International Group, LLP 0.00% Reduce -55.3% 70,817 $72K
Sanctuary Advisors, LLC 0.00% New 37,100 $63K
Squarepoint Ops LLC 0.00% Reduce -59.8% 55,418 $57K
Northern Trust Corp. 0.00% Reduce -87.6% 52,291 $53K
Goldman Sachs Group Inc. 0.00% Reduce -89.1% 50,241 $51K
Commonwealth Equity Services, LLC 0.00% Reduce -0.2% 50,000 $51K
Point72 Asia (Singapore) Pte. Ltd. 0.01% Reduce -30.9% 47,073 $48K
Jane Street Group, LLC 0.00% Reduce -84.2% 45,952 $47K
Bank of America Corp. 0.00% Reduce -59.5% 44,994 $46K
Virtu Financial LLC 0.00% New 43,388 $44K
Morgan Stanley 0.00% Reduce -50.6% 43,058 $44K
HSBC Holdings PLC 0.00% Reduce -16.0% 40,023 $41K
Qube Research & Technologies Ltd 0.00% Reduce -69.9% 36,438 $37K
XTX Topco Ltd 0.00% New 35,058 $36K
Barclays PLC 0.00% Reduce -3.1% 34,323 $35K
Earned Wealth Advisors, LLC 0.01% Reduce -3.0% 25,976 $26K
Cubist Systematic Strategies, LLC 0.00% Reduce -26.3% 23,621 $24K
Aptus Capital Advisors, LLC 0.00% Add +6.8% 22,337 $23K
Kestra Advisory Services, LLC 0.00% No change 16,000 $16K
Lido Advisors, LLC 0.00% No change 15,554 $16K
Finivi Inc. 0.01% No change 14,544 $15K
Altshuler Shaham Ltd 0.00% No change 12,142 $12K
Point72 (DIFC) Ltd 0.00% New 11,600 $12K
Catalyst Funds Management Pty Ltd 0.00% No change 10,200 $10K
Harbour Investment Management LLC 0.00% No change 10,100 $10K
TD Waterhouse Canada Inc. 0.00% No change 6,000 $6K
National Bank of Canada 0.00% Reduce -1.6% 6,000 $6K
Tower Research Capital LLC (TRC) 0.00% Reduce -71.7% 5,055 $5K
Simplex Trading, LLC 0.00% Add +4995.5% 3,414 $3K
Truvestments Capital LLC 0.00% New 2,458 $3K
JPMorgan Chase & Co. 0.00% No change 1,595 $2K
Activest Wealth Management 0.00% No change 300 $306
UBS Group AG 0.00% Reduce -4.9% 292 $298
Federation des caisses Desjardins du Quebec 0.00% No change 250 $255
Y.D. More Investments Ltd 0.00% No change 220 $224
Osaic Holdings, Inc. 0.00% Reduce -87.5% 200 $204
Arax Advisory Partners 0.00% No change 39 $40

"% of holder's portfolio" is PLX's weight in each manager's 13F, not the share of Protalix Biotherapeutics Inc. the manager owns.